QF
ONCE

QVT Financial’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

QVT Financial’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,500
Closed -$452K – 102
2015
Q2 		$452K Hold
7,500
– – 0.01% 84
2015
Q1 		$581K Buy
+7,500
New +$432K 0.03% 78

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RS Investment Management
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

QVT Financial's ONCE Position: Q3 2015 in Review

QVT Financial sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2015, closing a stake of 7,500 shares — an estimated $452K sold.

QVT Financial first reported a position in ONCE in Q1 2015 and held it in 2 quarters. The position peaked at $581K in Q1 2015. 90 funds tracked by Wall St. Rank hold ONCE as of Q3 2015.

  • QVT Financial reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • QVT Financial sold 7,500 Spark Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $452K.
  • QVT Financial first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • QVT Financial's Spark Therapeutics, Inc. Common Stock position peaked at $581K in Q1 2015.
  • 90 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2015.

Based on QVT Financial's 13F filing for Q3 2015, filed 16 Nov 2015.